468 related articles for article (PubMed ID: 31875667)
1. Reclassification of Korean patients with polymyositis and dermatomyositis based on the Bohan and Peter criteria by the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies.
Yoo J; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Korean J Intern Med; 2021 Mar; 36(2):441-446. PubMed ID: 31875667
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the 2017 EULAR/ACR criteria with Bohan and Peter criteria for the classification of idiopathic inflammatory myopathies.
Pinto B; Janardana R; Nadig R; Mahadevan A; Bhatt AS; Raj JM; Shobha V
Clin Rheumatol; 2019 Jul; 38(7):1931-1934. PubMed ID: 30903308
[TBL] [Abstract][Full Text] [Related]
3. Performance of the 2017 EULAR/ACR criteria for idiopathic inflammatory myopathies in a cohort of patients from Latin America.
Valenzuela A; Torres M; Devés JD
Medicine (Baltimore); 2022 Oct; 101(43):e31015. PubMed ID: 36316860
[TBL] [Abstract][Full Text] [Related]
4. First external validation of sensitivity and specificity of the European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) classification criteria for idiopathic inflammatory myopathies with a Japanese cohort.
Jinnin M; Ohta A; Ishihara S; Amano H; Atsumi T; Fujimoto M; Kanda T; Kawaguchi Y; Kawakami A; Mimori A; Mimori T; Mimura T; Muro Y; Sano H; Shimizu J; Takeuchi T; Tanaka Y; Yamamoto K; Sumida T; Kohsaka H;
Ann Rheum Dis; 2020 Mar; 79(3):387-392. PubMed ID: 31694813
[TBL] [Abstract][Full Text] [Related]
5. Frequency of EMG abnormalities in idiopathic inflammatory myopathies under the EULAR/ACR classification criteria.
Hokkoku K; Yamamoto J; Uchida Y; Kondo A; Mukai T; Hatanaka Y; Kono H; Shimizu J; Kobayashi S; Sonoo M
Medicine (Baltimore); 2024 Jan; 103(4):e37105. PubMed ID: 38277547
[TBL] [Abstract][Full Text] [Related]
6. Performance of the new EULAR/ACR classification criteria for idiopathic inflammatory myopathies (IIM) in a large monocentric IIM cohort.
Barsotti S; Dastmalchi M; Notarnicola A; Leclaire V; Dani L; Gheorghe K; Ekholm L; Bottai M; Tjärnlund A; Lundberg IE
Semin Arthritis Rheum; 2020 Jun; 50(3):492-497. PubMed ID: 32024593
[TBL] [Abstract][Full Text] [Related]
7. Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria in Patients With Idiopathic Inflammatory Myopathy and Anti-Melanoma Differentiation-Associated Protein 5 Positivity.
So H; So J; Lam TT; Wong VT; Ho R; Li WL; Mok CC; Lau CS; Tam LS
Arthritis Rheumatol; 2022 Sep; 74(9):1588-1592. PubMed ID: 35467787
[TBL] [Abstract][Full Text] [Related]
8. New Myositis Classification Criteria-What We Have Learned Since Bohan and Peter.
Leclair V; Lundberg IE
Curr Rheumatol Rep; 2018 Mar; 20(4):18. PubMed ID: 29550929
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the 2017 EULAR/ACR Criteria with Clinicoserologic Criteria for the Classification of Idiopathic Inflammatory Myopathies in Korean Patients.
Chung SW; Yoo IS; Kim J; Kang SW; Kwon M; Joung CI; Choi IA; Chang SH; Kang MI; Hong SJ; Lee YA
Yonsei Med J; 2021 May; 62(5):424-430. PubMed ID: 33908213
[TBL] [Abstract][Full Text] [Related]
10. The spectrum of idiopathic inflammatory myopathies in South Africa.
Chinniah KJ; Mody GM
Clin Rheumatol; 2021 Apr; 40(4):1437-1446. PubMed ID: 32212001
[TBL] [Abstract][Full Text] [Related]
11. Validation of 2017 classification criteria for adult and juvenile idiopathic inflammatory myopathies proposed by EULAR/ACR in Chinese patients.
Zhang X; Yang X; Ji L; Zhang Z
Int J Rheum Dis; 2019 Jul; 22(7):1278-1282. PubMed ID: 31124267
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic inflammatory myopathies in adults: A comparative study of Bohan and Peter and European Neuromuscular Center 2004 criteria.
Challa S; Jakati S; Uppin MS; Kannan MA; Liza R; Murthy Jagarlapudi MK
Neurol India; 2018; 66(3):767-771. PubMed ID: 29766941
[TBL] [Abstract][Full Text] [Related]
13. Applicability of EULAR/ACR classification criteria for dermatomyositis to amyopathic disease.
Patel B; Khan N; Werth VP
J Am Acad Dermatol; 2018 Jul; 79(1):77-83.e1. PubMed ID: 29291954
[TBL] [Abstract][Full Text] [Related]
14. Nailfold capillaroscopy changes with disease activity in patients with inflammatory myositis including overlap myositis, pure dermatomyositis, and pure polymyositis.
Shenavandeh S; Rashidi F
Reumatologia; 2022; 60(1):42-52. PubMed ID: 35645422
[TBL] [Abstract][Full Text] [Related]
15. Clinical profile of anti-NXP-2 antibody-positive inflammatory myositis and outcome in an Indian population.
Manwatkar A; Padiyar S; Nair A; Jha A; Kumar S; Yadav B; Prakash JAJ; Das JK; Mathew J
Clin Rheumatol; 2023 Dec; 42(12):3289-3297. PubMed ID: 37801141
[TBL] [Abstract][Full Text] [Related]
16. Performance of the Revised Classification Criteria for Systemic Autoimmune Rheumatic Diseases and Their Overlap Syndromes.
Inoue Y; Ogura T; Yamashita N; Takenaka S; Ito H; Hirata A; Katagiri T; Takakura Y; Imaizumi C; Mizushina K; Imamura M; Kujime R; Hayashi N; Kameda H
Intern Med; 2022; 61(13):1947-1952. PubMed ID: 35781270
[TBL] [Abstract][Full Text] [Related]
17. The balance between clinical convenience and the new concepts of the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies.
Kim HS
Korean J Intern Med; 2021 Mar; 36(2):288-291. PubMed ID: 33725435
[No Abstract] [Full Text] [Related]
18. The performance of the European League Against Rheumatism/American College of Rheumatology idiopathic inflammatory myopathies classification criteria in an expert-defined 10 year incident cohort.
Parker MJS; Oldroyd A; Roberts ME; Lilleker JB; Betteridge ZE; McHugh NJ; Herrick AL; Cooper RG; Chinoy H
Rheumatology (Oxford); 2019 Mar; 58(3):468-475. PubMed ID: 30496561
[TBL] [Abstract][Full Text] [Related]
19. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups.
Lundberg IE; Tjärnlund A; Bottai M; Werth VP; Pilkington C; Visser M; Alfredsson L; Amato AA; Barohn RJ; Liang MH; Singh JA; Aggarwal R; Arnardottir S; Chinoy H; Cooper RG; Dankó K; Dimachkie MM; Feldman BM; Torre IG; Gordon P; Hayashi T; Katz JD; Kohsaka H; Lachenbruch PA; Lang BA; Li Y; Oddis CV; Olesinska M; Reed AM; Rutkowska-Sak L; Sanner H; Selva-O'Callaghan A; Song YW; Vencovsky J; Ytterberg SR; Miller FW; Rider LG;
Ann Rheum Dis; 2017 Dec; 76(12):1955-1964. PubMed ID: 29079590
[TBL] [Abstract][Full Text] [Related]
20. Juvenile Dermatomyositis: Advances in Pathogenesis, Assessment, and Management.
Leung AKC; Lam JM; Alobaida S; Leong KF; Wong AHC
Curr Pediatr Rev; 2021; 17(4):273-287. PubMed ID: 33902423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
